Anne De Gheest

  • Managing Director, MedStars Ventures, Los Altos Hills, CA

    Anne DeGheest is managing partner at MedStars Ventures Partners. Since 1986, she is a mentor capitalist specializing in investing and mentoring early-stage start-ups in healthcare. The life science companies for which she has been a founder or an early advisor have generated over $6 billion in market capitalization and have raised over $500 million in venture capital. She provided angel capital, hands-on operating expertise and/or business strategy in the founding of major companies like Pyxis (CareFusion), Aspect Medical (acquired by Covidien), VISX (acquired by AMO), Thermage (merged into Solta Medical), VISICU(acquired by Philips), Masimo (Nasdaq: MASI). She also helped grow new entrepreneurial division of large corporations like Johnson & Johnson, Baxter, Medtronic and McKesson. She was also part of the founding executive team of Nellcor (a division of Covidien), MedPool and OmniCell (Nasdaq: OMCL). Anne founded in 2010 HealthTech Capital, a group of private investors dedicated to funding and mentoring new “HealthTech” start ups at the intersection of healthcare and the computer/consumer electronic world. She is still an active investor with Life Science Angels, an angel group focusing on funding early stage medical devices and biotech start ups. She is on the board of directors of Immersion Corp. (Nasdaq: IMMR) and HealthTech Capital. She is an early investor, board observer and advisor to Pixel Optics, Visioneering and other early stage medical devices. She was an Entrepreneur-In-Residence with Institutional Venture Partners and started her career at Raychem after receiving an MBA from Harvard and a Master in Business Engineering from University of Brussels.

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!